| HMDB0015558 | Pipotiazine | 39860-99-6 |   | C24H33N3O3S2 | 475.667 475.196333317 | - Kanba S, Suzuki E, Nomura S, Nakaki T, Yagi G, Asai M, Richelson E: Affinity of neuroleptics for D1 receptor of human brain striatum. J Psychiatry Neurosci. 1994 Jul;19(4):265-9. [PubMed:7918347  ] 
 
  | 
| HMDB0014557 | Pramipexole | 104632-26-0 |   | C10H17N3S | 211.327 211.114318249 | - Lam YW: Clinical pharmacology of dopamine agonists. Pharmacotherapy. 2000 Jan;20(1 Pt 2):17S-25S. [PubMed:10641988  ] 
 
  | 
| HMDB0013938 | Promazine 5-sulfoxide |  |   | C17H20N2OS | 300.418 300.129633962 | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284  ] 
 - Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423  ] 
 
  | 
| HMDB0015546 | Propericiazine | 2622-26-6 |   | C21H23N3OS | 365.492 365.156183063 | - Kanba S, Suzuki E, Nomura S, Nakaki T, Yagi G, Asai M, Richelson E: Affinity of neuroleptics for D1 receptor of human brain striatum. J Psychiatry Neurosci. 1994 Jul;19(4):265-9. [PubMed:7918347  ] 
 
  | 
| HMDB0014915 | Propiomazine | 362-29-8 |   | C20H24N2OS | 340.482 340.16093409 | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284  ] 
 - Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423  ] 
 
  | 
| HMDB0005021 | Quetiapine | 111974-69-7 |   | C21H25N3O2S | 383.507 383.166747749 | Not Available | 
| HMDB0014413 | Ropinirole | 91374-21-9 |   | C16H24N2O | 260.3746 260.1888634 | - Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. [PubMed:18691132  ] 
 
  | 
| HMDB0015615 | Rotigotine | 92206-54-7 |   | C19H25NOS | 315.473 315.165685117 | - Kvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67. [PubMed:18691132  ] 
 
  | 
| HMDB0014516 | Thiethylperazine | 1420-55-9 |   | C22H29N3S2 | 399.616 399.180289323 | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284  ] 
 - Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423  ] 
 
  | 
| HMDB0015559 | Thioproperazine | 316-81-4 |   | C22H30N4O2S2 | 446.629 446.181017604 | - Kanba S, Suzuki E, Nomura S, Nakaki T, Yagi G, Asai M, Richelson E: Affinity of neuroleptics for D1 receptor of human brain striatum. J Psychiatry Neurosci. 1994 Jul;19(4):265-9. [PubMed:7918347  ] 
 
  | 
| HMDB0014817 | Thioridazine | 50-52-2 |   | C21H26N2S2 | 370.575 370.153740222 | - Hammock RG, Schroeder SR, Levine WR: The effect of clozapine on self-injurious behavior. J Autism Dev Disord. 1995 Dec;25(6):611-26. [PubMed:8720030  ] 
 
  | 
| HMDB0015560 | Thiothixene | 5591-45-7 |   | C23H29N3O2S2 | 443.625 443.170118567 | - Kanba S, Suzuki E, Nomura S, Nakaki T, Yagi G, Asai M, Richelson E: Affinity of neuroleptics for D1 receptor of human brain striatum. J Psychiatry Neurosci. 1994 Jul;19(4):265-9. [PubMed:7918347  ] 
 - Shultz PJ, Sedor JR, Abboud HE: Dopaminergic stimulation of cAMP accumulation in cultured rat mesangial cells. Am J Physiol. 1987 Aug;253(2 Pt 2):H358-64. [PubMed:3039860  ] 
 
  | 
| HMDB0014650 | Triflupromazine | 146-54-3 |   | C18H19F3N2S | 352.417 352.122103923 | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284  ] 
 - Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423  ] 
 
  | 
| HMDB0014864 | Trimipramine | 739-71-9 |   | C20H26N2 | 294.4338 294.209598842 | - Berger M, Gastpar M: Trimipramine: a challenge to current concepts on antidepressives. Eur Arch Psychiatry Clin Neurosci. 1996;246(5):235-9. [PubMed:8863001  ] 
 
  | 
| HMDB0014391 | Ziprasidone | 146939-27-7 |   | C21H21ClN4OS | 412.936 412.112459711 | - Nasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11. [PubMed:17848919  ] 
 
  | 
| HMDB0015561 | Zuclopenthixol | 53772-83-1 |   | C22H25ClN2OS | 400.965 400.137611829 | - Lublin H, Gerlach J, Hagert U, Meidahl B, Molbjerg C, Pedersen V, Rendtorff C, Tolvanen E: Zuclopenthixol, a combined dopamine D1/D2 antagonist, versus haloperidol, a dopamine D2 antagonist, in tardive dyskinesia. Eur Neuropsychopharmacol. 1991 Dec;1(4):541-8. [PubMed:1822319  ] 
 - Manzaneque JM, Navarro JF: An ethopharmacological assessment of the effects of zuclopenthixol on agonistic interactions in male mice. Methods Find Exp Clin Pharmacol. 1999 Jan-Feb;21(1):11-5. [PubMed:10222441  ] 
 
  |